Most Read Articles
30 Apr 2016
New drug applications approved by US FDA as of 16 - 30 Apr 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
01 Sep 2015
A 10 to 35 minute time on the scene of cardiac arrest was linked with improved survival of paediatric patients, particularly adolescents, based on an observational study.
01 Sep 2015
Add-on omalizumab is safe and effective in patients with moderate to severe allergic asthma refractory to steroid treatment as shown in a systematic review of three randomised controlled trials.
Kavitha G. Shekar, 01 Aug 2015

Breastfeeding for 6 months or longer may lower the risk of developing childhood leukaemia, a meta-analysis and systematic review has shown.

Bacillus clausii spores: Assured viability for the effective treatment of diarrhoea

16 Mar 2017
Probiotics have a long history of use in humans. Defined as "live organisms that confer a health benefit on the host when administered in adequate amounts", the spectrum of use of probiotics in humans ranges from foods and dietary supplements to pharmaceutical/nutraceutical products to affect general health and disease. While the genera Lactobacillus and Bifidobacterium are the two most common probiotics associated with consumer products, there exist other organisms (eg, the yeast Saccharomyces cerevisiae, some non-pathogenic strains of Escherichia coli and Bacillus species) that are used as probiotics.1–3 One of them is the probiotic strain B. clausii that has been found to be effective for the treatment of diarrhoea and antibiotic-associated gastrointestinal side effects.4–6

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
30 Apr 2016
New drug applications approved by US FDA as of 16 - 30 Apr 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
01 Sep 2015
A 10 to 35 minute time on the scene of cardiac arrest was linked with improved survival of paediatric patients, particularly adolescents, based on an observational study.
01 Sep 2015
Add-on omalizumab is safe and effective in patients with moderate to severe allergic asthma refractory to steroid treatment as shown in a systematic review of three randomised controlled trials.
Kavitha G. Shekar, 01 Aug 2015

Breastfeeding for 6 months or longer may lower the risk of developing childhood leukaemia, a meta-analysis and systematic review has shown.